Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282964706> ?p ?o ?g. }
- W4282964706 abstract "Ivermectin which was widely considered as a potential treatment for COVID-19, showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials to evaluate the effectiveness of this drug in the midst of the pandemic, while difficult, has been urgently needed.We performed two large multicenter randomized, double-blind, placebo-controlled clinical trials evaluating the effectiveness of ivermectin in treating inpatients and outpatients with COVID-19 infection. The intervention group received ivermectin, 0.4mg/kg of body weight per day for 3 days. In the control group, placebo tablets were used for 3 days.Data for 609 inpatients and 549 outpatients were analyzed. In hospitalized patients, complete recovery was significantly higher in the ivermectin group (37%) compared to placebo group (28%; RR, 1.32 [95% CI, 1.04-1.66]; p-value = 0.02). On the other hand, the length of hospital stay was significantly longer in the ivermectin group with a mean of 7.98 ± 4.4 days compared to the placebo receiving group with a mean of 7.16 ± 3.2 days (RR, 0.80 [95% CI, 0.15-1.45]; p-value = 0.02). In outpatients, the mean duration of fever was significantly shorter (2.02 ± 0.11 days) in the ivermectin group versus (2.41 ± 0.13 days) placebo group with p value = 0.020. On the day seventh of treatment, fever (p-value = 0.040), cough (p-value = 0.019), and weakness (p-value = 0.002) were significantly higher in the placebo group compared to the ivermectin group. Among all outpatients, 7% in ivermectin group and 5% in placebo group needed to be hospitalized (RR, 1.36 [95% CI, 0.65-2.84]; p-value = 0.41). Also, the result of RT-PCR on day five after treatment was negative for 26% of patients in the ivermectin group versus 32% in the placebo group (RR, 0.81 [95% CI, 0.60-1.09]; p-value = 0.16).Our data showed, ivermectin, compared with placebo, did not have a significant potential effect on clinical improvement, reduced admission in ICU, need for invasive ventilation, and death in hospitalized patients; likewise, no evidence was found to support the prescription of ivermectin on recovery, reduced hospitalization and increased negative RT-PCR assay for SARS-CoV-2 5 days after treatment in outpatients. Our findings do not support the use of ivermectin to treat mild to severe forms of COVID-19.www.irct.ir IRCT20111224008507N5 and IRCT20111224008507N4." @default.
- W4282964706 created "2022-06-17" @default.
- W4282964706 creator A5002948253 @default.
- W4282964706 creator A5009919766 @default.
- W4282964706 creator A5010894628 @default.
- W4282964706 creator A5015202852 @default.
- W4282964706 creator A5017719452 @default.
- W4282964706 creator A5022426877 @default.
- W4282964706 creator A5026807124 @default.
- W4282964706 creator A5028796023 @default.
- W4282964706 creator A5031651486 @default.
- W4282964706 creator A5032033021 @default.
- W4282964706 creator A5033544451 @default.
- W4282964706 creator A5038031469 @default.
- W4282964706 creator A5045132438 @default.
- W4282964706 creator A5050186562 @default.
- W4282964706 creator A5053597634 @default.
- W4282964706 creator A5053820642 @default.
- W4282964706 creator A5054596639 @default.
- W4282964706 creator A5060462160 @default.
- W4282964706 creator A5065886766 @default.
- W4282964706 creator A5065984424 @default.
- W4282964706 creator A5067263527 @default.
- W4282964706 creator A5068795175 @default.
- W4282964706 creator A5074747983 @default.
- W4282964706 creator A5079938751 @default.
- W4282964706 creator A5084360723 @default.
- W4282964706 creator A5089936009 @default.
- W4282964706 creator A5090057212 @default.
- W4282964706 creator A5090908804 @default.
- W4282964706 creator A5091228091 @default.
- W4282964706 date "2022-06-16" @default.
- W4282964706 modified "2023-09-26" @default.
- W4282964706 title "Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials" @default.
- W4282964706 cites W1991496259 @default.
- W4282964706 cites W1993304187 @default.
- W4282964706 cites W2006810880 @default.
- W4282964706 cites W2071618337 @default.
- W4282964706 cites W2121584507 @default.
- W4282964706 cites W2171284733 @default.
- W4282964706 cites W2783142161 @default.
- W4282964706 cites W2981366800 @default.
- W4282964706 cites W3013187757 @default.
- W4282964706 cites W3014962324 @default.
- W4282964706 cites W3034823740 @default.
- W4282964706 cites W3043943819 @default.
- W4282964706 cites W3044548985 @default.
- W4282964706 cites W3082246640 @default.
- W4282964706 cites W3085495358 @default.
- W4282964706 cites W3091860795 @default.
- W4282964706 cites W3111036116 @default.
- W4282964706 cites W3111068209 @default.
- W4282964706 cites W3113296938 @default.
- W4282964706 cites W3121596699 @default.
- W4282964706 cites W3131672727 @default.
- W4282964706 cites W3133633583 @default.
- W4282964706 cites W3134437860 @default.
- W4282964706 cites W3135420706 @default.
- W4282964706 cites W3138483279 @default.
- W4282964706 cites W3139074783 @default.
- W4282964706 cites W3150247726 @default.
- W4282964706 cites W3157727129 @default.
- W4282964706 cites W3158220712 @default.
- W4282964706 cites W3165752295 @default.
- W4282964706 cites W3168908540 @default.
- W4282964706 cites W3170319714 @default.
- W4282964706 cites W3170745260 @default.
- W4282964706 cites W3173645873 @default.
- W4282964706 cites W3174188666 @default.
- W4282964706 cites W3197929425 @default.
- W4282964706 cites W3201540137 @default.
- W4282964706 cites W3205700591 @default.
- W4282964706 cites W3214011883 @default.
- W4282964706 cites W3217293035 @default.
- W4282964706 cites W4200412491 @default.
- W4282964706 cites W4211091790 @default.
- W4282964706 cites W4225677225 @default.
- W4282964706 doi "https://doi.org/10.3389/fmed.2022.919708" @default.
- W4282964706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35783616" @default.
- W4282964706 hasPublicationYear "2022" @default.
- W4282964706 type Work @default.
- W4282964706 citedByCount "7" @default.
- W4282964706 countsByYear W42829647062022 @default.
- W4282964706 countsByYear W42829647062023 @default.
- W4282964706 crossrefType "journal-article" @default.
- W4282964706 hasAuthorship W4282964706A5002948253 @default.
- W4282964706 hasAuthorship W4282964706A5009919766 @default.
- W4282964706 hasAuthorship W4282964706A5010894628 @default.
- W4282964706 hasAuthorship W4282964706A5015202852 @default.
- W4282964706 hasAuthorship W4282964706A5017719452 @default.
- W4282964706 hasAuthorship W4282964706A5022426877 @default.
- W4282964706 hasAuthorship W4282964706A5026807124 @default.
- W4282964706 hasAuthorship W4282964706A5028796023 @default.
- W4282964706 hasAuthorship W4282964706A5031651486 @default.
- W4282964706 hasAuthorship W4282964706A5032033021 @default.
- W4282964706 hasAuthorship W4282964706A5033544451 @default.
- W4282964706 hasAuthorship W4282964706A5038031469 @default.
- W4282964706 hasAuthorship W4282964706A5045132438 @default.
- W4282964706 hasAuthorship W4282964706A5050186562 @default.
- W4282964706 hasAuthorship W4282964706A5053597634 @default.